 Instead, they inhibit multiple MMPs, some of which have protective functions or are not related to pathology.MMPs have been regarded as promising targets for cancer therapy.Preclinical studies investigating the efficacy of MMP suppression in tumor models were encouraging.Following these results, clinical studies were conducted but turned out to be disappointing.